Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 Delivers 12% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for First Quarter 2024 Reports Adjusted Net Income of $634 Million, or Adjusted Diluted EPS of $1.38, for First Quarter 2024 Updates Full Year 2024... Read More

PARSIPPANY, N.J. & TEANECK, N.J. / Apr 28, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This... Read More

PARSIPPANY, N.J. / Apr 25, 2024 / Business Wire / As we celebrate World Veterinary Day, the Zoetis Foundation is proud to support veterinarians around the world today and everyday by providing grant support to initiatives promoting veterinary education, mental well-being, and livelihoods. Recognizing the invaluable role veterinarians and veterinary technicians play in advancing animal health, the Foundation is committed to... Read More

Molson Coors’ President and Chief Executive Officer brings valuable business leadership and global public company experience to Zoetis Board PARSIPPANY, N.J. / Apr 01, 2024 / Business Wire / Zoetis Inc . (NYSE: ZTS) today announced the appointment of Gavin D.K. Hattersley, President, Chief Executive Officer and Director of Molson Coors Beverage Company, to its Board of Directors. Mr. Hattersley brings global public company... Read More

PARSIPPANY, N.J. / Mar 28, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2024 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live... Read More

PARSIPPANY, N.J. / Mar 05, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:30 a.m. ET. Investors and other interested parties will be able to access a live audio webcast... Read More

PARSIPPANY, N.J. / Feb 21, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:40 a.m. ET. Investors and other interested parties will be able to access a... Read More

For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Respectively, on a Reported Basis Delivers 8% Operational Growth in Revenue and 6% Operational Growth in Adjusted Net Income for Fourth Quarter 2023 Reports Adjusted Net Income of $569 Million, or Adjusted Diluted EPS of $1.24, for Fourth Quarter 2023 For Full Year... Read More

PARSIPPANY, N.J. / Feb 06, 2024 / Business Wire / The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024. The dividend will be paid on Tuesday, June 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, April 19, 2024. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular... Read More

Prestigious award recognizes the company’s global initiative to advance Diversity, Equity and Inclusion (DE&I) Zoetis is the first animal health company to receive this honor PARSIPPANY, N.J. / Jan 18, 2024 / Business Wire / Zoetis Inc. (NYSE:ZTS) has been selected as a 2024 Catalyst Award recipient for its global initiative , Awareness and Action Drives Impact , that is advancing equity for women and other underrepresented... Read More

PARSIPPANY, N.J. / Dec 28, 2023 / Business Wire / Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may... Read More

PARSIPPANY, N.J. / Dec 21, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 3:45 p.m. PT. Investors and other interested parties will be able to access a live audio webcast of the presentation by... Read More

PARSIPPANY, N.J. / Dec 07, 2023 / Business Wire / The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the first quarter of 2024, an increase of 15% from the quarterly dividend rate paid in 2023. The dividend will be paid on Friday, March 1, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, January 19, 2024. “Zoetis has continued to... Read More

PARSIPPANY, N.J. / Nov 21, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. ET. Investors and other interested parties will be able to access a live... Read More

Reports Revenue of $2.2 Billion, Growing 7%, and Net Income of $596 Million, or $1.29 per Diluted Share, Increasing 13% and 14%, Respectively, on a Reported Basis for Third Quarter 2023 Delivers 8% Operational Growth in Revenue and a 13% Operational Growth in Adjusted Net Income for Third Quarter 2023 Reports Adjusted Net Income of $629 Million, or Adjusted Diluted EPS of $1.36, for Third Quarter 2023 Updates Full Year 2023... Read More

PARSIPPANY, N.J. / Oct 12, 2023 / Business Wire / The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth quarter of 2023. The dividend will be paid on Friday, December 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Wednesday, November 1, 2023. About Zoetis As the world’s leading animal health company, Zoetis is driven by a... Read More

Seramount recognized Zoetis for its inclusive benefits for families, including paid gender-neutral parental leave, subsidized childcare, bereavement leave after miscarriage, reimbursement for fertility expenses, increased mental health benefits for colleagues, and a flexible work environment Mary Bradley, Head of Colleague Experience Communications, Named Zoetis’ Working Mother of the Year Dr. Kevin Esch, Executive Director,... Read More

PARSIPPANY, N.J. / Sep 27, 2023 / Business Wire / Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 2, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live... Read More

$2.6 million pledged to six initiatives across Australia, Brazil, the United Kingdom, and the U.S. Commitments made to support veterinary scholarships and debt relief, mental well-being, diversity and inclusion initiatives, and livestock farmers and veterinary livelihoods around the world PARSIPPANY, N.J. / Sep 07, 2023 / Business Wire / Today, the Zoetis Foundation announced that it will distribute $2.6 million during its... Read More

PARSIPPANY, N.J. / Sep 06, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, Sept. 12, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:55 p.m. ET. Investors and other interested parties will be able to access a... Read More

DURHAM, N.C. / Aug 24, 2023 / Business Wire / Zoetis: NEWS FACTS Today, Zoetis, the world leader in Animal Health, marked the official opening of its new building dedicated to diagnostics and biodevices research and development with a ribbon cutting ceremony at its site in Durham, N.C. The ceremony was attended by local... Read More

DURHAM, N.C. / Aug 17, 2023 / Business Wire / Zoetis , the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of a new building dedicated to diagnostics and biodevices research and development (R&D) to meet the needs of veterinarians, livestock farmers and pet owners. The expanded site will serve as the hub for Zoetis’ engineering and... Read More

LINCOLN, Neb. / Aug 09, 2023 / Business Wire / Zoetis: NEWS FACTS Today, Zoetis, the world leader in Animal Health, marked the official opening of its new monoclonal antibodies (mAbs) expansion with a ribbon cutting ceremony at its site in Lincoln, Neb. The ceremony was attended by local officials, including U.S. Senator Pete... Read More

Reports Revenue of $2.2 Billion, Growing 6%, and Net Income of $671 Million, or $1.45 per Diluted Share, Increasing 27% and 29%, Respectively, on a Reported Basis for Second Quarter 2023 Delivers 9% Operational Growth in Revenue and a 12% Operational Growth in Adjusted Net Income for Second Quarter 2023 Reports Adjusted Net Income of $652 Million, or Adjusted Diluted EPS of $1.41, for Second Quarter 2023 Updates Full Year... Read More

LINCOLN, Neb. / Aug 04, 2023 / Business Wire / Zoetis , the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of our new monoclonal antibodies (mAbs) expansion, which will enable the site to increase production of products that control osteoarthritis pain in dogs and cats – our largest growing area of need for pet care customers. The... Read More

PARSIPPANY, N.J. / Jul 12, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) has been named to Fast Company’s list of Best Workplaces for Innovators for 2023 . Zoetis is the only stand-alone animal health company to be included on this year’s list which honors businesses that demonstrate a commitment to encouraging innovation at all levels. “Our innovative culture means we are always seeking to understand how we can meet our... Read More

PARSIPPANY, N.J. / Jul 10, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) today announced the addition of Ester Banque as Executive Vice President and President, U.S. Operations, for the company, effective July 10, 2023. Ms. Banque is an accomplished global senior executive with over 30 years of experience in health sciences... Read More

PARSIPPANY, N.J. / Jun 30, 2023 / Business Wire / Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 8, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live... Read More

$7.4 million in corporate giving invested in communities, and an additional $5.7 million distributed through Zoetis Foundation grants to support veterinarians and farmers Continued progress toward colleague diversity aspirations, including increased representation of women at the director level and above globally from 32% in 2020 to 37% in 2022, aspiring to reach 40% by 2025 Received approval for several livestock vaccines... Read More

PARSIPPANY, N.J. / May 30, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2023 Jaws and Paws Conference on Wednesday, May 31, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 3:35 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of... Read More

PARSIPPANY, N.J. / May 25, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade . During today’s presentations, Chief Executive... Read More

PARSIPPANY, N.J. / May 11, 2023 / Business Wire / The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the third quarter of 2023. The dividend will be paid on Friday, September 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, July 21, 2023. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular... Read More

Librela™ is the first and only injectable monoclonal antibody (mAb) treatment for the control of canine OA pain approved in the United States Zoetis continues to advance innovation with a new era of pain management for dogs PARSIPPANY, N.J. / May 05, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of... Read More

Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023 Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First Quarter 2023 Reports Adjusted Net Income of $607 Million, or Adjusted Diluted EPS of $1.31, for First Quarter 2023 Maintains Full Year 2023... Read More

PARSIPPANY, N.J. / May 01, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will host an Investor Day on Thursday, May 25, 2023, at the New York Stock Exchange featuring Kristin Peck, Chief Executive Officer; Wetteny Joseph, Chief Financial Officer; Robert Polzer, Ph.D., President of Research and Development; and other members of the Zoetis executive team. Zoetis will provide an update on the company’s strategy to deliver... Read More

$5.3 million pledged to 21 initiatives across Africa, Brazil, China, U.S. and for those impacted by the earthquake in Türkiye Commitments made to support veterinary scholarships, diversity and inclusion programming, mental well-being, livestock farmers and veterinary livelihoods around the world PARSIPPANY, N.J. / Apr 05, 2023 / Business Wire / Today, the Zoetis Foundation announced that it will distribute $5.3 million... Read More

PARSIPPANY, N.J. / Mar 30, 2023 / Business Wire / Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 4, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live... Read More

PARSIPPANY, N.J. / Mar 13, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies . In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of three pharmaceutical companies and the only standalone animal health company... Read More

PARSIPPANY, N.J. / Mar 03, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the TD Cowen Health Care Conference on Monday, March 6, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:10 a.m. ET. Investors and other interested parties will be able to access a live audio webcast of the... Read More

PARSIPPANY, N.J. / Mar 01, 2023 / Business Wire / Zoetis is pleased to receive a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate innovative solutions to advance veterinary care and diagnostic services that will ultimately improve livestock health and productivity in Sub-Saharan Africa. The grant will help Zoetis to expand its original African Livestock Productivity and Health... Read More

PARSIPPANY, N.J. / Feb 28, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2023 Animal Health Summit on Thursday, March 2, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:30 p.m. ET. Investors and other interested parties will be able to access a live... Read More

PARSIPPANY, N.J. / Feb 14, 2023 / Business Wire / Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023. The company reported revenue of $2.0 billion for the fourth quarter of 2022, which was an increase of 4% compared with the fourth quarter of 2021. On an operational 1 basis, revenue for the fourth quarter of 2022 increased 9% compared... Read More

PARSIPPANY, N.J. / Feb 08, 2023 / Business Wire / The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, April 21, 2023. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular... Read More

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2022 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis... Read More

Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. PT. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting... Read More